Renaud Tamisier Selected Research

Phentolamine (Z-Max)

8/2008	Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans.
11/2006	Evidence of impaired hypoxic vasodilation after intermediate-duration hypoxic exposure in humans.
5/2004	Evidence of sustained forearm vasodilatation after brief isocapnic hypoxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renaud Tamisier Research Topics

Disease

32	Obstructive Sleep Apnea 01/2022 - 08/2009
20	Apnea 01/2022 - 08/2009
19	Hypoxia (Hypoxemia) 10/2021 - 05/2004
16	Sleep Apnea Syndromes (Sleep Apnea) 01/2022 - 08/2009
11	Hypertension (High Blood Pressure) 12/2021 - 01/2012
9	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2013
8	Inflammation (Inflammations) 04/2022 - 08/2012
7	Sleepiness 01/2021 - 01/2013
7	Obesity 01/2020 - 08/2009
6	Disorders of Excessive Somnolence (Hypersomnia) 01/2022 - 03/2012
6	Hypercapnia 01/2019 - 04/2010
5	Atherosclerosis 01/2018 - 09/2012
5	Obesity Hypoventilation Syndrome (Pickwickian Syndrome) 03/2016 - 01/2007
4	Central Sleep Apnea (Central Sleep Apnea Syndrome) 12/2022 - 01/2018
4	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 10/2017
4	Insulin Resistance 10/2019 - 01/2013
4	Hypoventilation 01/2019 - 05/2012
3	Heart Failure 12/2022 - 01/2020
3	COVID-19 11/2021 - 10/2020
3	Fatigue 01/2020 - 08/2013
3	Sleep Deprivation 01/2020 - 10/2011
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 11/2014
3	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2018 - 07/2015
3	Non-alcoholic Fatty Liver Disease 01/2017 - 06/2015
2	Headache (Headaches) 01/2021 - 01/2020
2	Necrosis 01/2019 - 01/2017
2	Alcoholic Fatty Liver 11/2018 - 02/2016
2	Fatty Liver 02/2016 - 03/2014
2	Vascular Remodeling 04/2014 - 09/2012
2	Hyperventilation 12/2011 - 03/2010
1	Type 2 Diabetes Mellitus (MODY) 11/2021
1	Body Weight (Weight, Body) 11/2021
1	Morbid Obesity 11/2021
1	Neuromuscular Diseases (Neuromuscular Disease) 04/2021
1	Muscular Diseases (Myopathy) 04/2021
1	Stroke (Strokes) 01/2021
1	Overweight 01/2020
1	Hypercholesterolemia 01/2020
1	Lymphedema (Milroy Disease) 01/2020
1	Ventilator-Associated Pneumonia 01/2020
1	Nausea 01/2020
1	Toxoplasmosis 01/2020
1	Vertigo (Positional Vertigo) 01/2020
1	Overbite 09/2019
1	Pain (Aches) 09/2019
1	Hyperoxia 01/2019

Drug/Important Bio-Agent (IBA)

8	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2009
7	Oxygen (Dioxygen)IBA 01/2020 - 09/2007
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2013
5	Endothelin-1 (Endothelin 1)IBA 01/2018 - 01/2009
4	Triglycerides (Triacylglycerol)IBA 01/2020 - 03/2014
3	LipidsIBA 04/2022 - 01/2014
3	DiureticsIBA 12/2021 - 01/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 11/2014
3	GasesIBA 10/2020 - 12/2011
3	Carbon DioxideIBA 01/2020 - 10/2011
3	LeptinIBA 01/2019 - 03/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2013
3	C-Reactive ProteinIBA 01/2019 - 03/2012
3	Messenger RNA (mRNA)IBA 01/2018 - 08/2007
3	CytokinesIBA 01/2017 - 03/2012
3	Chemokine CCL5IBA 05/2013 - 08/2009
3	Phentolamine (Z-Max)FDA LinkGeneric 08/2008 - 05/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 04/2017
2	pitolisantIBA 01/2021 - 01/2020
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2020 - 04/2010
2	Insulin (Novolin)FDA Link 10/2019 - 01/2013
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2019 - 02/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 05/2013
2	Indicators and Reagents (Reagents)IBA 09/2018 - 09/2012
2	LeukotrienesIBA 01/2018 - 08/2009
2	ApolipoproteinsIBA 01/2018 - 08/2013
2	cysteinyl-leukotrieneIBA 01/2018 - 08/2009
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2007
2	Bicarbonates (Hydrogen Carbonate)IBA 03/2016 - 08/2012
2	Angiotensin IIIBA 12/2015 - 03/2010
1	hydroxide ionIBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 10/2021
1	cadherin 5IBA 10/2021
1	AntioxidantsIBA 10/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2021
1	Phosphotransferases (Kinase)IBA 10/2021
1	Baclofen FDA LinkGeneric 01/2021
1	CholesterolIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 10/2019
1	Adiponectin ReceptorsIBA 01/2019
1	P-SelectinIBA 01/2019
1	pro-brain natriuretic peptide (1-76)IBA 01/2019

Therapy/Procedure

39	Continuous Positive Airway Pressure 01/2022 - 08/2009
17	Therapeutics 12/2022 - 01/2014
9	Noninvasive Ventilation 11/2021 - 01/2007
2	Occlusal Splints 01/2019 - 01/2017
2	Perioperative Period 01/2018 - 01/2016
1	Bariatric Surgery 11/2021
1	Length of Stay 01/2020
1	Cardiac Resynchronization Therapy 01/2019
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2019